cephalexin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Busaidi, I; Bridgford, P; Gardiner, SJ; Hagedoorn, NN; Hudson, B; Walls, T | 1 |
1 other study(ies) available for cephalexin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Longitudinal trends in community antibiotic consumption in the Waitaha Canterbury Region of Aotearoa New Zealand over 10 years (2012-2021): an observational study.
Topics: Anti-Bacterial Agents; Cephalexin; COVID-19; Drug Utilization; Humans; New Zealand; World Health Organization | 2023 |